![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig2_HTML.png)
glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]
Description
Our findings strongly suggest the answer is yes. Primes recent real-world study found 63% of high-potency GLP-1 (Wegovy or Zepbound) users who started treatment in Q1 2024 are still taking their medication after a year
![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
No Botox needed.
![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://sydenhamclinic.com/wp-content/uploads/2022/08/9185eb_20772a96806a4dd291c540ad345b6df7_mv2.webp)
These providers prescribe exclusively or primarily FDA-approved brand-name GLP-1 medications Ozempic, Wegovy, Zepbound, Mounjaro, and Saxenda
![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5627/6812410/bb080c52f5cf/gr5.jpg)
Berberine is not a GLP-1 agonist, though both compounds influence metabolic pathways
![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62cf/11771532/b9541cd4137d/cureus-0016-00000076519-i01.jpg)
It does not titrate up
![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://www.nejm.org/cms/10.1056/NEJMcibr2409089/asset/1f854e14-bfd6-40e1-8b1c-03461c2a1ab4/assets/images/large/nejmcibr2409089_f1.jpg)
By 2022, 44% of women were overweight, and 18% were obese
![glp 1 drugs mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy glp-1_analogs [TUSOM | Pharmwiki]](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3867158207681329564)
